ArriVent BioPharma Ownership | Who Owns ArriVent BioPharma?

ArriVent BioPharma Ownership Summary

ArriVent BioPharma is owned by 35.79% institutional investors, 9.74% insiders, and 54.46% retail investors. Hhlr advisors is the largest institutional shareholder, holding 14.25% of AVBP shares.

AVBP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ArriVent BioPharma	35.79%	9.74%	54.46%
Sector	Healthcare Stocks	279.19%	10.58%	-189.76%
Industry	Biotech Stocks	63.97%	10.68%	25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Hhlr advisors	4.48M	14.25%	$82.92M
Orbimed advisors	3.03M	9.62%	$55.98M
Novo	1.87M	5.95%	$34.62M
Sofinnova investments	1.70M	5.39%	$31.37M
Millennium management	158.06K	0.50%	$2.92M
Tudor investment corp et al	15.29K	0.05%	$282.77K
Sectoral asset management	10.09K	0.03%	$186.56K
Quadrant capital group	-	-	-
Virtus etf advisers	-	-	-
Aqr capital management	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Novo	1.87M	2.63%	$34.62M
Hhlr advisors	4.48M	2.34%	$82.92M
Sofinnova investments	1.70M	2.05%	$31.37M
Orbimed advisors	3.03M	1.34%	$55.98M
Sectoral asset management	10.09K	0.15%	$186.56K
Millennium management	158.06K	0.00%	$2.92M
Tudor investment corp et al	15.29K	0.00%	$282.77K
Quadrant capital group	-	-	-
Virtus etf advisers	-	-	-
Aqr capital management	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Novo	1.87M	2.63%	351.51K
Millennium management	158.06K	0.00%	105.51K
Tudor investment corp et al	15.29K	0.00%	15.29K
Sectoral asset management	10.09K	0.15%	10.09K
Sofinnova investments	1.70M	2.05%	-

Top Sellers

Holder	Shares	% Assets	Change
Octagon capital advisors lp	-	-	-2.06M
Cormorant asset management, lp	-	-	-585.46K
Proshare advisors	-	-	-9.53K
Aqr capital management	-	-	-8.87K
Virtus etf advisers	-	-	-2.75K

New Positions

Holder	Shares	% Assets	Change	Value
Tudor investment corp et al	15.29K	0.00%	15.29K	$282.77K
Sectoral asset management	10.09K	0.15%	10.09K	$186.56K

Sold Out

Holder	Change
Parallel advisors	-3.00
Advisor group	-17.00
Quadrant capital group	-21.00
Ronald blue trust	-39.00
Srs capital advisors	-119.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	7	-91.14%	11,264,335	-59.25%	35	0.53%	4	-92.98%	-	-100.00%
Dec 31, 2024	81	20.90%	28,465,927	9.87%	84	1.42%	58	7.41%	11	266.67%
Sep 30, 2024	67	26.42%	25,908,140	19.65%	77	1.85%	54	58.82%	3	-57.14%
Jun 30, 2024	53	-	21,652,506	-0.91%	64	1.52%	34	-35.85%	7	-
Mar 31, 2024	53	-	21,851,944	-	65	-	53	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 30, 2024	HILLHOUSE INVESTMENT MANAGEMENT, LTD.	-	Buy	$10.00M
Jan 30, 2024	ORBIMED ADVISORS LLC		Buy	$4.00M
Jan 30, 2024	GORDON CARL L		Buy	$4.00M
Jan 30, 2024	HEALY JAMES	-	Buy	$8.00M

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2024 Q1	4	-

AVBP Ownership FAQ

Who Owns ArriVent BioPharma?

ArriVent BioPharma shareholders are primarily institutional investors at 35.79%, followed by 9.74% insiders and 54.47% retail investors. The average institutional ownership in ArriVent BioPharma's industry, Biotech Stocks , is 63.97%, which ArriVent BioPharma falls below.

Who owns the most shares of ArriVent BioPharma?

ArriVent BioPharma’s largest shareholders are Hhlr advisors (4.48M shares, 14.25%), Orbimed advisors (3.03M shares, 9.62%), and Novo (1.87M shares, 5.95%). Together, they hold 29.82% of ArriVent BioPharma’s total shares outstanding.

Does Blackrock own ArriVent BioPharma?

BlackRock is not among the top 10 institutional shareholders of ArriVent BioPharma.

Who is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested?

Novo is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested, with 2.63% of its assets in 1.87M ArriVent BioPharma shares, valued at 34.62M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools